Close Menu

NEW YORK – Abbott announced today that its high-sensitivity troponin-I blood test to detect heart attacks has received clearance from the US Food and Drug Administration.

The Architect Stat blood test measures low levels of troponin to help doctors in emergency rooms diagnose patients with heart attacks within two to four hours of admission to the hospital. The test is cleared for use on Abbott's Architect analyzer, and the company said it should be used with other diagnostic information, such as electrocardiograms and clinical observations.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.